中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 6
Jun.  2008

硫普罗宁联合维生素E治疗酒精性脂肪肝疗效的临床观察

  • Published Date: 2008-06-20
  • Objective To study the therapeutic effect and safety of tiopionin combined with Vitamin E for alcoholic fatty liver (AFL) .Methods 72 patients with AFL were randomly divided into two groups.The treatment group (n=46) was treated with 0.2g tiopionin once daily by intravenous drip and 100mg Vitamin E two daily by orally taken.The control group (n=26) was given 0.6g glucurolactone once daily by intravenous drip and 0.4g inosine three daily by orally taken.The treated course for both group was one month.Before and after treatment, clinical data including main symptoms and signs, adverse drug reactions, hepatic function, blood grease and fatty liver image B ultrasonic wave of the two groups were monitored respectively.Results After treatment the symptoms and signs of the treatment group were better than those of the control group.Total effective rate of the treatment group (80.4%) was higher than that of the control group (46.2%) (P<0.01) .The levels of AST, ALT, γ-GT and triglyceride (TG) were more declinced in the treatment group than the control group (P<0.01) , but there were no significant different for TBil and total cholesterol (TC) between the two groups.There were 3 cases of skin eruption, 2 cases of fever and 4 cases of gastrointestinal reaction observed in treatment group.Conclusion Tiopionin combined with Vitamin E has good clinical efficacy for the treatment of alcoholic fatty liver disease, the adverse effects must be observed in treatment.

     

  • [1]中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊断标准[J].中华肝脏病杂志, 2003, 11 (2) :72.
    [2]范建高, 曾民德.脂肪肝[M].上海:上海医科大学出版社, 2000:127-130.
    [3]Bellentani S, Saccoccio G, Costa G, et al.Drinking habits as cofac-tors of risk for alcohol induced liver damage[J].Gut, 1997, 41:840-850.
    [4]张晓景.硫普罗宁的药理作用及临床应用[J].中国药业, 2005, 14 (8) :91-92.
    [5]Hasegewa T, Yonede M, Nakamura K, et al.Plasma transforming growth factor-betal level and efficacy of alphatocopherol in patients with non-alcoholic steatohepatitis:a pilot study[J].Aliment Phar-macol Ther, 2001, 15 (10) :1667-1672.
  • Relative Articles

    [1]Chengzuo HAN, Qiang WEI, Xiao XU. Transplant oncology creates a new era of liver transplantation for the treatment of liver cancer[J]. Journal of Clinical Hepatology, 2021, 37(2): 253-256. doi: 10.3969/j.issn.1001-5256.2021.02.002
    [2]Liu ShenShen, Xing YiQing, Wang Ning, Yu QiaoLing, Ceng LePing. Clinical effect of vitamin E in treatment of nonalcoholic fatty liver disease in children: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(7): 1545-1550. doi: 10.3969/j.issn.1001-5256.2020.07.019
    [3]Jiang MinJie, Song LiSha, Xin GuiJie, Gao PuJun. Low-molecular-weight heparin sodium for the treatment of hepatic sinusoidal obstruction syndrome: A case report[J]. Journal of Clinical Hepatology, 2019, 35(7): 1594-1595. doi: 10.3969/j.issn.1001-5256.2019.07.035
    [5]Luo JingYi, Zhang LiTing, Lu MingXia, Liu YaLi, Xiao Ping. Systematic review of metformin versus vitamin E in treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2014, 30(12): 1319-1324. doi: 10.3969/j.issn.1001-5256.2014.12.021
    [7]Gong YuanYing. A clinical observation on metadoxine combined with tiopronin in the treatment of patients with alcoholic liver disease[J]. Journal of Clinical Hepatology, 2012, 28(1): 48-49+52.
    [8]Qin YongJun, Sun JieSheng, Wang BingYuan, Liu PengLiang, Sun FuRong, Liu CuiXiang, Xie DaWei. The differences of the blood routine indexes in patients with fatty liver and non-fatty liver[J]. Journal of Clinical Hepatology, 2010, 26(2): 163-166.
    [9]Zhan GuoQing, Zheng SanJu, Zhu Lin, Li JinKe, Hu Bo, Xie XingRong. Protective effect of tiopionin on liver injury caused by transcatheter arterial chemoembolization in liver carcinoma.[J]. Journal of Clinical Hepatology, 2009, 25(1): 48-50.
    [11]Zhan GuoQing, Wang ChongHui, Zhu Lin. Clinical study on phentolamine mesilate, thymosin α1 combined with PHGF in the treatment of severe hepatitis.[J]. Journal of Clinical Hepatology, 2008, 24(3): 191-193.
  • Cited by

    Periodical cited type(14)

    1. 许岩岩. 凝血酶原时间与血小板参数检验对肝硬化患者肝损伤情况的评估作用. 临床医学研究与实践. 2024(08): 93-96 .
    2. 陈大同,孙跃,梁明辉,金成,李公启,许东滨,张立平. 基于深度学习的淋巴细胞热图分析及红细胞计数预测老年原发性肝癌患者术后生存期的临床价值. 中国老年学杂志. 2024(08): 1813-1816 .
    3. 张月华,马玉琳,任爱莉,张月靖. 网织红细胞血红蛋白含量在诊断单采血小板铁缺乏中的应用. 系统医学. 2024(09): 33-37 .
    4. 王燚鑫,胡梦茹,赵永红,衣桂荣,陈爱荣. TyG、PLR与代谢相关脂肪性肝病合并慢性乙型肝炎患者肝纤维化的关系研究. 现代生物医学进展. 2024(14): 2694-2698+2693 .
    5. 刘华柱,张欢,张献文. 失代偿期肝硬化患者门静脉血栓形成的相关因素分析及D-二聚体/血小板比值的预测价值. 临床消化病杂志. 2024(04): 270-274 .
    6. 王凯,郭爱荣,王艳. PLT、IGFBP-3、ALB联合诊断对肝硬化上消化道出血的预测价值. 华夏医学. 2024(04): 145-150 .
    7. 张嘉欣,韩文,葛彪,白莆菥. 肝硬化食管胃底静脉曲张无创预测的研究进展. 肝脏. 2024(08): 1005-1009 .
    8. 孔钦香,盛吉芳. 慢性乙肝肝硬化患者肝性脑病不同分级与肝脏储备功能的相关性. 中国微生态学杂志. 2023(02): 190-196 .
    9. 田丽,许勤华,郭旭. RPR预测感染性休克患者发生急性呼吸窘迫综合征的价值. 河南医学高等专科学校学报. 2023(01): 13-17 .
    10. 于巧丽,张丽利. 非酒精性脂肪性肝炎外周血NLR、RDW、MPV变化及其意义探讨. 罕少疾病杂志. 2023(04): 65-66+81 .
    11. 何宏材,苏鹏宇,侯立朝,樊海宁. 红细胞分布宽度与血小板计数比值和血小板-白蛋白-胆红素评分预测肝脏多房棘球蚴病术后并发症的列线图构建. 中国普外基础与临床杂志. 2023(07): 795-801 .
    12. 张小娟,马昕. 红细胞分布宽度与血小板计数比值与慢性阻塞性肺疾病急性发作风险的相关性分析. 检验医学与临床. 2023(19): 2885-2888 .
    13. 梁忆佳,李金洋,赵氲. 肝硬化患者凝血酶原时间及血小板指标检验的临床价值. 中国老年学杂志. 2023(22): 5458-5460 .
    14. 王广春,曹洋. 红细胞分布宽度及其衍生物作为消化系统炎症和肿瘤疾病标志物的研究进展. 南京医科大学学报(自然科学版). 2023(12): 1764-1770 .

    Other cited types(4)

  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 7.0 %FULLTEXT: 7.0 %META: 89.4 %META: 89.4 %PDF: 3.6 %PDF: 3.6 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 1.8 %其他: 1.8 %其他: 0.6 %其他: 0.6 %China: 0.3 %China: 0.3 %Malaysia: 0.9 %Malaysia: 0.9 %United States: 0.3 %United States: 0.3 %[]: 0.3 %[]: 0.3 %上海: 3.3 %上海: 3.3 %保定: 0.3 %保定: 0.3 %北京: 12.2 %北京: 12.2 %南宁: 0.9 %南宁: 0.9 %台州: 0.9 %台州: 0.9 %吉林: 0.6 %吉林: 0.6 %哥伦布: 0.3 %哥伦布: 0.3 %大庆: 0.3 %大庆: 0.3 %大连: 0.3 %大连: 0.3 %天津: 0.3 %天津: 0.3 %张家口: 2.1 %张家口: 2.1 %扬州: 0.3 %扬州: 0.3 %新加坡: 0.3 %新加坡: 0.3 %昌吉回族自治州: 0.3 %昌吉回族自治州: 0.3 %景德镇: 0.3 %景德镇: 0.3 %杭州: 0.6 %杭州: 0.6 %武汉: 0.3 %武汉: 0.3 %泸州: 0.3 %泸州: 0.3 %济南: 0.6 %济南: 0.6 %湖州: 0.3 %湖州: 0.3 %漯河: 0.6 %漯河: 0.6 %石家庄: 0.9 %石家庄: 0.9 %芒廷维尤: 38.3 %芒廷维尤: 38.3 %苏州: 0.3 %苏州: 0.3 %莫斯科: 0.3 %莫斯科: 0.3 %西宁: 28.6 %西宁: 28.6 %邯郸: 0.3 %邯郸: 0.3 %长春: 1.5 %长春: 1.5 %其他其他ChinaMalaysiaUnited States[]上海保定北京南宁台州吉林哥伦布大庆大连天津张家口扬州新加坡昌吉回族自治州景德镇杭州武汉泸州济南湖州漯河石家庄芒廷维尤苏州莫斯科西宁邯郸长春

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2309) PDF downloads(768) Cited by(18)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return